Successive property slumps in the UK have persuaded mortgage lenders to take a cautious view on who they should lend money to. Most rely on credit scoring based on salary data. If in doubt, mortgage applications are chucked out.
But evidence that the Bank of England has learned how to control inflation, and hence house price surges and slumps, has now provided market newcomer Kensington with an opportunity.
Kensington was due to be listed on the main market as Growth Company Investor went to press. The company, run by ex-Abbey National executive, John Maltby, sets out to lend to individuals whose wealth profile does not conform to the norm. Its chairman is Peter Birch, former chief executive of Abbey, who is proud of his business record, and would have a great deal to lose if Kensington went wrong.Using technology and skilled intermediaries, the company assesses the potential of individuals to service mortgages on a wider basis than just annual remuneration. Its experts are skilled in credit analysis: they will take a view on lending someone money if the interest they pay is priced to take account of credit risk.
The prospective bonuses earned by an investment banker would, for example, count in their favour. The self-employed, older borrowers and people who have previously experienced credit problems would also be Kensington customers. Loans made are then packaged up and resold to other lenders through securitisation.
Crucially, this is not a start-up. Kensington, founded by ex-Goldman Sachs senior trader Martin Finegold, has put together a string of lending packages since 1994. It has carried out 11 loan portfolio securitisations totalling more than £1.75 billion. There are now nearly 18,000 Kensington borrowers.
Profits are growing nicely. In the year to November 1998, Kensington made pre-tax profits of £3.9 million. In 1998-9, it made £9.6 million. In the half year to May this year, profits totalled £7.5 million. The company is forecasting £19 million for the full year, and £27 million is in prospect for 2000-1.
The company outsources administration to Skipton Building Society. It concentrates its efforts on making sure that borrowers are sufficiently wealthy, creditworthy and honest, using a data warehouse which makes full use of the internet to make the information available to both Kensington management and specially trained intermediaries.
Despite Kensington's growth record, its shares are being sold cheaply because 37 per cent shareholder, Ocwen Financial Corporation of the US, needs the cash to achieve its own restructuring. Kensington is raising an additional £34 million to spend on its own business.
Reasonable profit forecasts would suggest that the shares are being sold on an earnings multiple of 7.5, based on 2000-1 forecasts, which compares with average multiples of 13 achieved by quoted consumer finance operations Cattles and London Scottish Bank.
Maltby's presentations have gone down well with institutions, corralled by advisers Schroder Salomon Smith Barney, ABN Amro Rothschild, Bear Sterns and Investec Henderson Crosthwaite. ÊIt is not often that blue chip firms such as these work together on a new issue whose market value looks likely to total just £150 million at inception.
All concerned must believe that the company has something good going for it. One perception is that Kensington will attract a bid from a traditional mortgage lender.
As Growth Company Investor went to press, the price at which Kensington shares were to be sold had not been finalised. But 250p, at the lower end of expectations, was on the cards. A price target of 350p is seen as feasible, and investors should consider buying the stock at levels below this.
Growth Company Investor is the leading magazine for investors in AIM and boasts award-winning research and analysis coverage.
Subscribe now and receive a 50% discount
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Fast-growing Alliance Pharma is to buy most of Cambridge Laboratories' trade and assets for £14.3m and £16.4m.
Investors seeking to back a business with exceptionally high earnings visibility and a burgeoning order book should look no further than Norwich-based infrastructure services specialist May Gurney.
Staff rostering software specialist Allocate, buoyed by 27% organic growth in the six months to November, aims to speed expansion with several acquisitions in coming years.